Evaluation of p53 mutation as a predictive biomarker for outcome to chemotherapy in ovarian cancer.
A. H. Calvert
No relevant relationships to disclose
J. C. Jackson
No relevant relationships to disclose
C. Hutton
No relevant relationships to disclose
A. M. Swart
No relevant relationships to disclose
W. Qian
No relevant relationships to disclose
C. Kwakye
No relevant relationships to disclose
R. Fossati
No relevant relationships to disclose
A. Lissoni
No relevant relationships to disclose
P. G. Harper
No relevant relationships to disclose
N. Colombo
No relevant relationships to disclose
R. J. Edmondson
No relevant relationships to disclose
J. Lunec
No relevant relationships to disclose